Documents
Cat#: VRS-0124-YT5242
Lenti-EBOV GP Pseudovirus [EGFP, HIV-1 Packaging System]
EBOV GP Pseudovirus is produced by cotransfecting 293T cells with the plasmid encoding EBOV GP protein and pHR'EGFP. Pseudovirus-containing supernatant was harvested 24 h following transfection. The supernatant was cleared of cell debris by centrifugation and filtered through a 0.45-μm-pore-size filter. The produced pseudoviruses carry EBOV GP proteins, which is a powerful tool for EBOV vaccine and entry inhibitor research.
Made to Order Requirements
Your choose infomation:
CLEAR(Note: Please select the requirements to fit you project. If you have any other requirements, please specify. If no specific requirements, you don't need to select any button.)
- Product Summary
- Packaging, Storage & Formulations
- Target Details
Product Summary
| Type : | Pseudovirus |
| Virus Name : | Ebola Virus |
| Virus Packaging Protein : | GP |
| Packaging System : | HIV-1 Packaging System |
| Packaging Cell : | 293T |
| Reporter Gene : | EGFP |
| Titer : | >1x 108 virus copies/mL |
| Application Notes : | The pseudovirus can be usd for the following applications: 1. Antibody neutralization assay, Serum neutralization assay. 2. As virus standard alternative in diagnostic assay or others. 3. Drug screening including vaccine development, viral entry inhibitor development. 4. As a safe virology tool to discover the virus entry mechanisms. |
Packaging, Storage & Formulations
| Form : | Liquid |
| Storage : | Store at -80°C and stable for 6 months from the date of shipment, avoiding freeze/thaw cycles. |
| Shipping : | Dry ice |
| Note : | The pseudovirus can be used under BSL-2 conditions. Please reach out to our scientists for detailed instructions or guidelines of the pseudovirus. |
Target Details
| Introduction : | Ebola viruses (EBOVs) are the cause of repeated outbreaks of fatal infections, including the recent deadly epidemic in West Africa. The EBOV has a membrane envelope decorated by trimers of a glycoprotein (GP) which is cleaved by furin to form GP1 and GP2 subunits). GP is solely responsible for host cell attachment, endosomal entry and membrane fusion, thus becoming a primary target for the development of antiviral drugs. |
| Alternative Names : | GP; GP1,2, Envelope glycoprotein; EBOV structural polyprotein |
| Gene ID : | 911829 |
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
pepFastX™ Platform
If no antibody is available for your research, we recommend our novel pepFastX™ antibody discovery platform. The mAb products can be delivered within 2-3 months.
Learn more
We're here to help
Get expert recommendations for common problems or connect directly with an on staff expert for technical assistance related to applications, equipment and general product use.
Contact tech support